Elekta AB (publ) (OTCMKTS:EKTAY) Share Price Passes Below Fifty Day Moving Average – What’s Next?

Elekta AB (publ) (OTCMKTS:EKTAY)’s stock price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $6.60 and traded as low as $5.93. Elekta AB (publ) shares last traded at $5.96, with a volume of 11,730 shares.

Elekta AB (publ) Stock Performance

The stock has a market cap of $2.28 billion, a P/E ratio of 18.61 and a beta of 1.21. The stock has a fifty day simple moving average of $6.60 and a 200-day simple moving average of $6.69. The company has a quick ratio of 0.74, a current ratio of 0.99 and a debt-to-equity ratio of 0.45.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, August 28th. The company reported $0.04 EPS for the quarter. Elekta AB (publ) had a net margin of 6.25% and a return on equity of 12.23%. The firm had revenue of $359.76 million during the quarter. Equities analysts expect that Elekta AB will post 0.41 earnings per share for the current fiscal year.

Elekta AB (publ) Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, September 27th. Shareholders of record on Monday, September 9th were paid a $0.114 dividend. The ex-dividend date of this dividend was Monday, September 9th. Elekta AB (publ)’s payout ratio is 34.38%.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.